Miscellaneous & Research
Cerebralisin
Last updated
Evidence on file1 randomised human trial · 1 human observational study
Strongest sourceCerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Tr… (randomised human trial)
Dosing on file unverified
No established human dose; preclinical only
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 2
-
human RCT
Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial (Stroke 2016, cited 120x) graded on: randomised and placebo-controlled — “Randomized, Placebo-Controlled”
-
human observational
Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials (Neurological Sciences 2017, cited 102x) graded on: a synthesis of human studies — “meta-analysis”
Notes unverified prose
No human RCTs identified; preclinical only; no FDA approval; No human RCTs; preclinical
Not on file 8
8 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- molecular weightnothing we hold supplies it
- molecular formulanothing we hold supplies it
- CAS registry numbernothing we hold supplies it
- PubChem identifiernothing we hold supplies it
- amino-acid sequencenothing we hold supplies it
- SMILES stringnothing we hold supplies it
- InChInothing we hold supplies it
- InChI keynothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.